Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm — Carla Colombo (2023) | RDL Network
Management of hypertension during lenvatinib for advanced thyroid cancer: a suggested diagnostic and therapeutic algorithm
Article 2023 en
Authors
CC
Carla Colombo
DC
Daniele Ceruti
SL
Simone De Leo
Abstract
1 min read
HTN is a frequent and early AE in patients on LEN treatment. We suggest a diagnostic and therapeutic algorithm to be applied in clinical practice to allow efficient HTN control and improve patient compliance, reducing LEN discontinuation.
Gianfranco Parati, Alexandra Gonçalves, David G. Soergel, Rosa María Bruno, Enrico G. Caiani, Eva Gerdts, Felix Mahfoud, LG Mantovani, Richard J. McManus, Paola Santalucia, Thomas Kahan
Se Jin Park, Hyo Soon An, Sung Hye Kim, Seong Heon Kim, Heeyeon Cho, Jae Hyun Kim, Anna Cho, Ji Hee Kwak, Jae Il Shin, Keum Hwa Lee, Jin-Hee Oh, Jung Won Lee, Hae Soon Kim, Hye-Jung Shin, Mi Young Han, Myung Chul Hyun, Tae‐Sun Ha, Young Hwan Song
Discussion(0)
No comments yet. Be the first to comment.